Browse our 650+ Publications​

Latest Publications

Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo

McGoldrick et al.
Blood
Papers
April 2013
Authors and Affiliates
Suzanne M. McGoldrick,1,2 Marie E. Bleakley,1,2 Abraham Guerrero,1 Cameron J. Turtle,1,2 Tori N. Yamamoto,1 Shalini E. Pereira,1,2 Colleen S. Delaney,1,2 and Stanley R. Riddell1,3 1Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA. 2University of Washington, School of Medicine, Seattle, WA; and 3Institute for Advanced Study, Technical University of Munich, Munich, Germany.

The Restricted DH Gene Reading Frame Usage in the Expressed Human Antibody Repertoire Is Selected Based upon its Amino Acid Content

Benichou et al.
Journal of Immunology
Papers
April 2013
Authors and Affiliates
Benichou J, Glanville J, Prak EL, Azran R, Kuo T, Pons J, Desmarais C, Tsaban L, Louzoun Y *The Mina & Everard Goodman Faculty of Life Sciences, Bar Ilan University †Protein Engineering and Applied Quantitative Genotherapeutics, Rinat-Pfizer Inc. Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania Department of Mathematics and Gonda Brain Research Center, Bar-Ilan University ¶Adaptive Biotechnologies

Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia

Grupp et al.
New England Journal of Medicine
Papers
April 2013
Authors and Affiliates
Grupp SA1,2, Kalos M2,3, Barrett D1, Aplenc R1,2, Porter DL2,4, Rheingold SR1,2, Teachey DT1,2, Chew A3, Hauck B3, Wright JF1,3, Milone MC2,3, Levine BL2,3, June CH2,3 1 Children’s Hospital of Philadelphia, Department of Pediatrics. 2Abramson Cancer Center 3University of Pennsylvania, Department of Pathology and Laboratory Medicine 4University of Pennsylvania, Department of Medicine

Using synthetic templates to design an unbiased multiplex PCR assay

Carlson et al.
Nature Communications
Papers
April 2013
Authors and Affiliates
Carlson CS1, Emerson RO2, Sherwood AM2, Desmarais C2, Chung MW2, Parsons JM2, Steen MS2, LaMadrid-Herrmannsfeldt MA2, Williamson DW2, Livingston RJ2, Wu D3, Wood BL3, Rieder MJ2, Robins H1, 2. 1Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, Washington 98109, USA 2Adaptive Biotechnologies, Seattle, Washington, USA. 3Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA.

Fractal Organization of the Human T Cell Repertoire in Health and After Stem Cell Transplantation

Meier et al.
Biology of Blood Marrow Transplant
Papers
March 2013
Authors and Affiliates
Jeremy Meier1, Catherine Roberts1, Kassi Avent2, Allison Hazlett1, Jennifer Berrie2, Kyle Payne2, David Hamm3, Cindy Desmarais3, Catherine Sanders3, Kevin T. Hogan4, Kellie J. Archer5, Masoud H. Manjili2, Amir A. Toor1. 1Bone Marrow Transplant Program, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA. 2Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, Virginia. 3Adaptive Biotechnologies, Seattle, Washington. 4Massey Cancer Center, Richmond, Virginia. 5Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

Brentjens et al.
Papers
Science Translational Medicine
March 2013
Authors and Affiliates
Brentjens RJ1, Davila ML, Riviere I, Park J, Wang X, Cowell LG, Bartido S, Stefanski J, Taylor C, Olszewska M, Borquez-Ojeda O, Qu J, Wasielewska T, He Q, Bernal Y, Rijo IV, Hedvat C, Kobos R, Curran K, Steinherz P, Jurcic J, Rosenblat T, Maslak P, Frattini M, Sadelain M. 1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.

Immune Recovery in Adult Patients Following Myeloablative Dual Umbilical Cord Blood, Matched Sibling, and Matched Unrelated Donor Hematopoietic Cell Transplantation

Kanda et al.
Biology of Blood and Marrow Transplantation
Papers
December 2012
Authors and Affiliates
Junya Kanda, MD,1,6,* Lun-Wei Chiou, MD,1,* Paul Szabolcs, MD,2 Gregory D. Sempowski, PhD,3 David A. Rizzieri, MD,1 Gwynn D. Long, MD,1 Keith M. Sullivan, MD,1 Cristina Gasparetto, MD,1 John P. Chute, MD,1 Ashley Morris, PharmD,1 Jacalyn McPherson,1 Jeffrey Hale,3 John Andrew Livingston, MD,1 Gloria Broadwater, MS,4 Donna Niedzwiecki, PhD,5 Nelson J. Chao, MD,1 and Mitchell E. Horwitz, MD1,** 1Division of Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC 2Department of Pediatrics, Duke University Medical Center, Durham, NC 3Department of Medicine and Human Vaccine Institute, Duke University School of Medicine, Durham, NC 4Cancer Statistical Center, Duke University Medical Center, Durham, NC 5Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC 6Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan. **Corresponding author: Mitchell E. Horwitz, MD, Division of Cellular Therapy, Department of Medicine, Duke University Medical Center, 2400 Pratt Street, DUMC 3961, Durham, NC 27705, USA. *J.K. and L.C. equally contributed to this work.